Iodide I-123

DB09420ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Iodide I-123 is a radiopharmaceutical diagnostic agent used for the evaluation of the thyroid function and/or morphology. Following oral administration, I-123 is absorbed through the gastrointestinal tract and is taken up by the thyroid gland.

Chemical structure of Iodide I-123
Mechanism
Curator reviewed
Primary indication
Administration of Sodium Iodide I 123 Capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.Curator reviewed · 2 structured indications
Formula / weight
I · 122.9061 g/mol (avg)
First approval
United States, 2003
Also known as
123I− · I 123 · I-123 · I123 · Iodine 123

Resolves to

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
19Marketed productsAcross 2 countries and 6 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Iodide I-123, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account